Introduction
Patients with autoimmune diseases like lupus or rheumatoid arthritis, or those with connective tissue diseases, frequently experience respiratory issues that can become serious. When people have an autoimmune disease, their immune system targets the lungs, leading to inflammation and scarring that may make breathing difficult. A set of lung disorders known as rheumatoid lung disease can be brought on by rheumatoid arthritis. These include dyspnea or shortness of breath brought on by inflammation and fluid-filled lung lining (pleural effusion). Pulmonary hypertension and interstitial lung disease (ILD), which includes pulmonary fibrosis and pulmonary sarcoidosis, are common lung issues in patients with connective tissue illness. Lung nodules and bronchiectasis can also be seen in autoimmune disease patients.
What Is the Lung Pathology in Rheumatoid Arthritis?
A consequence of rheumatoid arthritis (RA) that is becoming more widely recognized is interstitial lung disease (ILD), which has a high rate of morbidity and mortality. Furthermore, subclinical illness with variable degrees of functional impairment affects about one-third of the patients. Though known risk factors (for example., age, male sex, ever smoked, seropositivity for rheumatoid factor, and anti-cyclic citrullinated peptide) for RA-related interstitial lung disease exist. Interstitial lung disease (ILD), which causes inflammation and fibrosis in the lung parenchyma, frequently exacerbates systemic inflammatory illnesses like rheumatoid arthritis (explain). In the absence of an autoimmune illness, interstitial lung disease (chronic lung disorders that cause scarring of the lung tissue) can also develop on its own. People with mutations in the autoimmune regulator (AIRE) gene experience autoimmune polyendocrine syndrome type 1 (APS1), which can affect the lungs in certain cases.
Rheumatoid arthritis-related respiratory symptoms may result from several illnesses affecting the parenchyma, pleura, airways, or vasculature. The immune-modulating drugs used to treat rheumatoid arthritis may also cause complications, or the involvement of rheumatoid arthritis itself may cause complications. Most respiratory symptoms appear during the first five years of the illness. Respiratory symptoms may appear before particular symptoms in ten to twenty percent of cases. However, persistent inflammation or low functional status due to joint illness may disguise them.
Autoantibodies commonly seen in circulation in patients with rheumatoid arthritis include anti-cyclic citrullinated peptide (CCP) and rheumatoid factor. Before the start of a clinical condition, these antibodies may be seen in the serum for a few years. Anti-CCP and rheumatoid factors have both been connected to the onset of ILD, especially at high titers. The development of airway disease has also been linked to anti-CCP antibodies. A subset of individuals who have lung illness and are anti-CCP positive but do not exhibit particular symptoms lend weight to the expanding body of research suggesting that rheumatoid arthritis develops in the lungs.
How Rheumatoid ArthritisAffects the Lungs and Pulmonary System?
Though its main symptoms are related to joint inflammation, rheumatoid arthritis can also result in pulmonary complications. Sometimes, the joint swelling and pain associated with rheumatoid arthritis are preceded by respiratory issues.
The following pulmonary issues are most frequently associated with rheumatoid arthritis:
1. Pleural Disease: Inflammation can occur in the pleura, the tissue that surrounds the lungs. A fluid accumulation (pleural effusion) between the pleura's two layers is frequently seen alongside pleural inflammation. The fluid may occasionally resolve itself. In addition, pleural illness might result in fever and dyspnea (difficulty in breathing).
2. Small Airway Obstruction: Inflammation or injury can induce bronchiectasis (a condition in which the lung airway gets damaged), persistent inflammation and infection, bronchiolitis, or thickening of the walls of the tiny airways of the lungs. In addition to shortness of breath, a persistent dry cough, exhaustion, and weakness may result in mucus accumulation in the lungs.
3. Scarring Within the Lungs: Shortness of breath, a persistent dry cough, exhaustion, weakness, and appetite loss can all be symptoms of interstitial lung disease, a scarring associated with chronic inflammation.
4. Lung Nodules: Rheumatoid nodules are small lumps that can develop in the lungs and other regions of the body. There is no danger of lung cancer associated with lung nodules, and they often show no symptoms. On the other hand, nodules have the potential to burst and collapse lungs.
How Does Lupus Affect the Lungs and Pulmonary System?
Lupus-related inflammation can impact the lungs in various ways, including the diaphragm, the blood vessels inside the lungs, the lungs themselves, and the membrane covering the lungs.
1. Heart-Related Emboli: Pulmonary emboli are blood clots that obstruct the arteries receiving blood supply to the lungs. These blood clots can result in decreased oxygen flow in the lungs, chest discomfort, and dyspnoea (difficulty breathing). People who have vascular damage, antiphospholipid antibodies, or an inactive lifestyle are more likely to experience pulmonary emboli.
2. Pleuritis: The most frequent way that lupus can impact the lungs is by inflaming the pleura, which is the lining that surrounds the lungs. One may have significant, frequently sharp, stabbing pain in one or more specific locations of the chest. The condition known as pleurisy is exacerbated by deep breathing, coughing, sneezing, laughing, or other respiratory movements. The person may also experience breathlessness. Pleural effusions develop when excessive fluid leaks out of the area between the chest wall and the lungs. Forty to sixty percent of lupus patients experience pleurisy pain, either with or without effusions.
3. Pneumonitis: Pneumonitis is the term used to describe inflammation within the lung tissue. Possible signs of pneumonitis include fever, coughing, shortness of breath, and chest pain. Pneumonitis is most commonly caused by an illness brought on by bacteria, viruses, or fungi.
4. Chronic Diffuse Interstitial Lung Disease: Chronic pulmonary inflammation can result in scarring. Diffuse, or broad, interstitial lung illness may result from this scar tissue's ability to obstruct the blood's ability to absorb oxygen from the lungs. A persistent dry cough, chest pain, and breathing difficulties when exercising are some of the symptoms one may encounter.
Conclusion
In RA, lung issues are frequent. Although they do not usually cause any symptoms, for some persons, they are the primary RA symptoms. The etiology of RA-related pulmonary illness remains unclear. RA medications, particularly Methotrexate, can occasionally cause lung disease. Most patients with systemic lupus erythematosus (SLE) have lung, pleura, diaphragm, or pulmonary vasculature involvement at some point during their illness. The earliest signs of lung involvement or SLE are frequently pleurisy, coughing, or dyspnea. Lung transplantation is a possibility in extreme circumstances. This is more prevalent in patients with pulmonary fibrosis, pulmonary hypertension, or bronchiolitis obliterans.
